Table 2.
agent | outflow resistancea | stiffness | junctional resistanceb | reference |
---|---|---|---|---|
colchicine | ↓ | ↓ | ? | [47–49] |
cytochalasin D | ↓ | ↓ | ↓ | [31,47,50–53] |
dibutyryl-cAMP | ↓ | ↓d | ↑ | [17–19,32,50,54] |
forskolin | ↓− | ↓ | ↑↓ | [19,32,54–57] |
isoproterenol | ↓− | ↓d | ↑↓ | [17,20–23,32,50,57] |
latrunculin | ↓ | ↓d | ? | [15,31,58] |
Y-27632 | ↓ | ↓d | ↓ | [14,16,31] |
butanedione monoxime | ↓ | ↓ | ? | [59,60] |
bradykinin | ↑ | ↑ | ↓ | [32,61–63] |
histamine | ↑ | ↑ | ↓ | [32,52,61,63] |
thrombin | ↑ | ↑d | ↓ | [14,54,61,64,65] |
lysophosphatidic acid | ↑ | ↑d | ↑↓ | [13,52,66–68] |
sphingosine 1-phosphate | ↑ | ↑d | ↑ | [12,13,69,70] |
dexamethasone | ↑ | ↑ | ↑ | [71–74] |
triamcinolone acetonide | ↑ | ↑ | ↑c | [71,75,76] |
aOutflow resistance is the inverse of outflow facility.
bJunctional resistance as determined from electrical resistance, hydraulic conductivity or permeability to solutes.
cResponse to corticosteroid.
dMeasurements on SC cells from this study.